RYAN MACKINNON VASAPOLI AND BERZOK, LLP for NOVO NORDISK
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
S. 1002 SAFE DOSES Act and H.R. 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (TPP): biosimilar provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Taxation/Internal Revenue Code TAX
H.R. 436- Protect Medical Innovation Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Health Issues HCR
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Medicare/Medicaid MMM
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741 Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Budget/Appropriations BUD
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to preventive health legislation (scoring)); National Diabetes Prevention Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Pharmacy PHA
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD, Chief Counsel, LA Rep. Stupak & Deutsch |
| NICK KOLOVOS | LA Rep. Anna Eshoo (D-California) |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (R-Texas) |
| JEFFERY C MORTIER | Staff on Energy & Commerce Committee |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min. Counsel, Energy&Comm, Special Asst. DOE |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.